Role of sex, gonadectomy and sex hormones in the development of nitric oxide inhibition-induced hypertension

Experimental Physiology

Volumn 89, Issue 2, 2004, Pages 155-162

  Sáinz, Juan ^a   Osuna, Antonio ^c   Wangensteen, Rosemary ^a   de Dios Luna, Juan ^a   Rodríguez Gómez, Isabel ^a   Duarte, Juan ^b   Moreno, Juan Manuel ^c   Vargas, Félix ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; SEX HORMONE; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; FEMALE; GONADECTOMY; HEART VENTRICLE HYPERTROPHY; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; ORCHIECTOMY; OVARIECTOMY; PLASMA RENIN ACTIVITY; PROTEINURIA; RAT; SEX DIFFERENCE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 17044442440     PISSN: 09580670     EISSN: None     Source Type: Journal    
DOI: 10.1113/expphysiol.2003.002652     Document Type: Article

References (38)

1. Ashton N & Balment RJ (1991). Sexual dimorphism in renal functions and hormonal status of New Zealand genetically hypertensive rats. Acta Endocrinol (Copenh) 124, 91-97.
2. Bradford MM (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye-binding. Anal Biochem 72, 248-254.
3. Chen YF (1996). Sexual dimorphism of hypertension. Curr Opin Nephrol Hypertens 6, 181-185.
4. Chen YF & Meng QC (1991). Sexual dimorphism of blood pressure in spontaneously hypertensive rats is androgen dependent. Life Sci 48, 85-96.
5. Chen YF, Naftilan AJ & Oparil S (1992). Androgen-dependent angiotensinogen and renin messenger RNA expression in hypertensive rats. Hypertension 19, 456-463.
6. Chen Z, Yuhanna IS, Galcheva-Gargova ZI, Karas RH, Mendelsohn ME & Shaul PW (1999). Estrogen receptor α mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 103, 401-406.
7. Chini EN, de Toledo FG, Thompson MA & Dousa TP (1997). Effect of estrogen upon cyclic ADP ribose metabolism: β-estradiol stimulates ADP ribosyl cyclase in rat uterus. Proc Natl Acad Sci U S A 94, 5872-5876.
8. Colby HD, Skelton FR & Brownie AC (1970). Testosterone-induced hypertension in the rat. Endocrinology 86, 1093-1101.
9. Crofton JT & Share L (1997). Gonadal hormones modulate deoxycorticosterone-salt hypertension in male and female rats. Hypertension 29, 494-499.
10. Crofton JT, Share L & Brooks DP (1989). Gonadectomy abolishes the sexual dimorphism in DOC-salt hypertension in the rat. Clin Exp Hypertens A11, 1249-1261.
11. Davidoff M, Caffier H & Schiebler TH (1980). Steroid hormone binding receptors in the rat kidney. Histochemistry 69, 39-48.
12. De Gracia MC, Osuna A, O'Valle F, Del Moral RG, Wangensteen R, García del Río C & Vargas F (2000). Deoxycorticosterone suppresses the effects of losartan in nitric oxide-deficient hypertensive rats. J Am Soc Nephrol 11, 1995-2000.
13. Devereux RB, Pickering TG, Alderman MH, Chien S, Borer JS & Laragh JH (1987). Left ventricular hypertrophy in hypertension. Prevalence and relationship to pathophysiologic variables. Hypertension 9 (Suppl. II), II-53-II-60.
14. Ellison KE, Ingelfinger JR, Pivor M & Dzau VJ (1989). Androgen regulation of rat renal angiotensinogen messenger RNA expression. J Clin Invest 83, 1941-1945.
15. Fortepiani LA, Rodrigo L, Ortiz MC, Cachofeiro V, Atucha NM, Ruilope LM, Lahera V & García-Estañ J (1999). Pressure natriuresis in nitric oxide-deficient hypertensive rats: Effect of antihypertensive treatments. J Am Soc Nephrol 10, 21-27.
16. Garavaglia GE, Messerli FH, Schmeider RE, Nunez BD & Oren S (1989). Sex differences in cardiac adaptation to essential hypertension. Eur Heart J 10, 1110-1114.
17. George FW, Russell DW & Wilson JD (1991). Feed-forward control of prostate growth: Dihydrotestosterone induces expression of its own biosynthetic enzyme, steroid 5α-reductase. Proc Natl Acad Sci U S A 88, 8044-8047.
18. Haber ET, Koerner LB, Page B, Kilman B & Purnode A (1969). Application of radioimmunoassay for angiotensin I to the physiologic measurement of plasma renin activity in normal human subject. J Clin Endocrinol Metab 29, 1349-1355.
19. Katz FH & Roper EF (1977). Testosterone effect on renin system in rats. Proc Soc Exp Biol Medical 155, 330-333.
20. Malyusz M, Ehrens HJ & Wrigge P (1985). Effects of castration on the experimental renal hypertension of the rat. Nephron 40, 96-99.
21. Masubuchi Y, Kumai T, Uematsu A, Komoriyama K & Hirai M (1982). Gonadectomy-induced reduction in blood pressure in adult spontaneously hypertensive rats. Acta Endocrinol (Copenh) 101, 154-160.
22. Nielsen AH, Johannessen A & Poulsen K (1989). Inactive plasma renin exhibits sex difference in mice. Clin Sci 76, 439-446.
23. Ouchi Y, Share L, Crofton JT, Iitake K & Brooks DP (1987). Sex differences in the development of deoxycorticosterone-salt hypertension in the rat. Hypertension 9, 172-177.
24. Reckelhoff JF (2001). Gender differences in the regulation of blood pressure. Hypertension 37, 1199-1208.
25. Reckelhoff JF, Hennington BS, Moore AG, Blanchard EJ & Cameron J (1998a). Gender differences in the renal nitric oxide (NO) system. Dissociation between expression of endothelial NO synthase and renal hemodynamic response to NO synthase inhibition. Am J Hypertens 11, 97-104.
26. Reckelhoff JF, Zhang H & Granger JP (1998b). Testosterone exacerbates hypertension and reduces pressure-natriuresis in male spontaneously hypertensive rats. Hypertension 31, 435-439.
27. Reckelhoff JF, Zhang H, Srivastava K & Granger JP (1999). Gender differences in hypertension in spontaneously hypertensive rats: role of androgens and androgen receptor. Hypertension 34, 920-923.
28. Rees DD, Palmer RM, Schulz R, Hodson HF & Moncada S (1990). Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 101, 746-752.
29. Rowland NE & Fregly MJ (1992). Role of gonadal hormones in hypertension in the Dahl salt-sensitive rat. Clin Exp Hypertens A14, 367-375.
30. Sáinz J, Osuna A, Wangensteen R, Duarte J & Vargas F (2000). Influence of gender on the development of nitric oxide inhibition-induced hypertension. Hypertension 36, 660.
31. Sasaki T, Ohno Y, Otsuka K, Suzawa T, Suzuki H & Saruta T (2000). Oestrogen attenuates the increases in blood pressure and platelet aggregation in ovariectomized and salt-loaded Dahl salt-sensitive rats. J Hypertens 18, 911-917.
32. Sealey JE, Atlas SA & Larga JH (1980). Prorenin and other large molecular weight forms of renin. Endocr Rev 1, 365-391.
33. Selye H & Pentz EI (1943). Pathogenetical correlations between periarteritis nodosa, renal hypertension and rheumatic lesions. Can Med Assoc J 49, 264-272.
34. Skelton FR (1956). Adrenal regeneration hypertension and factors influencing its development. Arch Intern Med 98, 449-462.
35. Sturtevant FM (1958). The biology of metacorticoid hypertension. Ann Int Med 49, 1281-1293.
36. Verhagen AM, Attia DM, Koomans HA & Joles JA (2000). Male gender increases sensitivity to proteinuria induced by mild NOS inhibition in rats: Role of sex hormones. Am J Physiol Renal Physiol 279, F664-670.
37. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG & Moncada S (1994). Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci U S A 91, 5212-5216.
38. Zatz R & Baylis C (1998). Chronic nitric oxide inhibition model six years on. Hypertension 32, 958-964.